Nucleic acid testing capacity improved
China's capacity and efficiency for nucleic acid testing have been improved so infections can be tracked in a timelier manner and the dynamic zero-COVID policy can be more effectively implemented, the country's top health regulator said.
The country's testing capacity has risen to 51.65 million samples a day. At present, 13,100 medical institutes are able to test samples and nearly 150,000 technicians are currently engaged in testing work, according to statistics released by the National Health Commission on Saturday.
A total of 37 reagents used for testing samples have been approved and test results are generally issued within six hours, the commission said, adding detection strategies and methods are also being optimized and promoted.